Jan‐Willem B. de Groot

1.1k citations

12 papers · 183 indexed · h-index 8

Endocrinology, Diabetes and Metabolism
Oncology
- Pancreatic and Hepatic Oncology Research 4
- CAR-T cell therapy research 3
- Cutaneous Melanoma Detection and Management 2
- Colorectal Cancer Surgical Treatments 2
- Cancer Immunotherapy and Biomarkers 2
- Colorectal Cancer Treatments and Studies 2
Cancer Research
- Cancer Genomics and Diagnostics 2
Pathology and Forensic Medicine
Pulmonary and Respiratory Medicine
Molecular Biology
- Melanoma and MAPK Pathways 3

Co-authors: John Th. M. Plukker Jan Osinga Maria M. Alves Thera P. Links Hans H G Verbeek Robert M.W. Hofstra Jennifer M. J. Schreinemakers Inne H.M. Borel Rinkes
Cited by: Endocrinology, Diabetes and Metabolism Oncology Cancer Research
Journals: The Journal of Clinical Endocrinology & Metabolism (1 paper)British Journal of Cancer (1 paper)International Journal of Cancer (1 paper)
Partner nations: Netherlands Germany United States

In The Last Decade

Jan‐Willem B. de Groot

12 papers receiving 179 citations

Peers

Countries citing papers authored by Jan‐Willem B. de Groot

Since Specialization

Citations

This map shows the geographic impact of Jan‐Willem B. de Groot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan‐Willem B. de Groot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan‐Willem B. de Groot more than expected).

Fields of papers citing papers by Jan‐Willem B. de Groot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan‐Willem B. de Groot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan‐Willem B. de Groot. The network helps show where Jan‐Willem B. de Groot may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jan‐Willem B. de Groot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jan‐Willem B. de Groot Line = papers co-authored together Jan‐Willem B. de Groot links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work
1	Added value of digital FDG-PET/CT in disease staging and restaging in patients with resectable or borderline resectable pancreatic cancer Surgical Oncology ·Tonke L. de Jong,Daniëlle Koopman,Corné A.J. van der Worp,Henk Stevens,Floris A. Vuijk,Alexander L. Vahrmeijer,J. Sven D. Mieog,Jan‐Willem B. de Groot,Maarten A.C. Meijssen,Vincent B. Nieuwenhuijs,Lioe‐Fee de Geus‐Oei,Pieter L. Jager,Gijs A. Patijn	2023	8
2	Response to checkpoint inhibition and targeted therapy in melanoma patients with concurrent haematological malignancies European Journal of Cancer ·Olivier J. van Not,Alfons J.M. van den Eertwegh,John B.A.G. Haanen,Rozemarijn S. van Rijn,Maureen J.B. Aarts,Franchette W.P.J. van den Berkmortel,Christian U. Blank,Marye J. Boers‐Sonderen,Mick J M van Eijs,Jan‐Willem B. de Groot,Geke A.P. Hospers,Ellen Kapiteijn,Melissa de Meza,Djura Piersma,Marion Stevense,Astrid A.M. van der Veldt,Gerard Vreugdenhil,Michel W.J.M. Wouters,Karijn P.M. Suijkerbuijk,Willeke A.M. Blokx	2023	2
3	Timing of start of systemic treatment in patients with asymptomatic metastasized pancreatic cancer (TIMEPAN): a protocol of a multicenter prospective patient preference non-randomized trial Acta Oncologica ·Simone Augustinus,Thijmen Broekman,Geert‐Jan Creemers,Lois A. Daamen,Susan van Dieren,Jan‐Willem B. de Groot,Geert A. Cirkel,Marjolein Y.V. Homs,Hanneke W.M. van Laarhoven,Lobke van Leeuwen,Maartje Los,Saskia Luelmo,Martijn G.H. van Oijen,Leontine E.A.M.M. Spierings,Judith de Vos‐Geelen,Marc G. Besselink,Johanna W. Wilmink,(unknown)	2023	2
4	Sex, Gender and Age Differences in Treatment Allocation and Survival of Patients With Metastatic Pancreatic Cancer: A Nationwide Study Frontiers in Oncology ·Esther N. Pijnappel,Melinda S. Schuurman,Dorothea Wagner,Judith de Vos‐Geelen,Lydia G. van der Geest,Jan‐Willem B. de Groot,Bas Groot Koerkamp,Ignace H. J. T. de Hingh,Marjolein Y.V. Homs,Geert‐Jan Creemers,Geert A. Cirkel,Hjalmar C. van Santvoort,Olivier R. Busch,Marc G. Besselink,Casper H.J. van Eijck,Johanna W. Wilmink,Hanneke W. M. van Laarhoven	2022	14
5	First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis British Journal of Cancer ·Jesper van Breeschoten,Michel W.J.M. Wouters,Doranne L. Hilarius,John B.A.G. Haanen,Christian U. Blank,Maureen J.B. Aarts,Franchette W.P.J. van den Berkmortel,Jan‐Willem B. de Groot,Geke A.P. Hospers,Ellen Kapiteijn,Djura Piersma,Roos S. van Rijn,Karijn P.M. Suijkerbuijk,Willeke A.M. Blokx,Bert-Jan J. ten Tije,Astrid A.M. van der Veldt,Art Vreugdenhil,Marye J. Boers‐Sonderen,Alfonsus Johannes Maria van den Eertwegh	2021	15
6	Discontinuation of anti‐PD‐1 monotherapy in advanced melanoma—Outcomes of daily clinical practice International Journal of Cancer ·Michiel C.T. van Zeijl,Alfons J.M. van den Eertwegh,Michel W.J.M. Wouters,Liesbeth C. de Wreede,Maureen J.B. Aarts,Franchette W.P.J. van den Berkmortel,Jan‐Willem B. de Groot,Geke A.P. Hospers,Ellen Kapiteijn,Djura Piersma,Rozemarijn S. van Rijn,Karijn P.M. Suijkerbuijk,Albert J. ten Tije,Astrid A.M. van der Veldt,Gerard Vreugdenhil,Jacobus J. M. van der Hoeven,John B.A.G. Haanen	2021	18
7	Delayed TME Surgery in a Watch-and-Wait Strategy After Neoadjuvant Chemoradiotherapy for Rectal Cancer: An Analysis of Hospital Costs and Surgical and Oncological Outcomes Diseases of the Colon & Rectum ·Vincent Meyer,R R Meuzelaar,Ivonne J. H. Schoenaker,Jan‐Willem B. de Groot,O. Reerink,Wouter H. de Vos tot Nederveen Cappel,Geerard L. Beets,Henderik L. van Westreenen	2021	6
8	Relationship Between Quality of Life and Survival in Patients With Pancreatic and Periampullary Cancer: A Multicenter Cohort Analysis Journal of the National Comprehensive Cancer Network ·Tara M. Mackay,Anouk E.J. Latenstein,Mirjam A. G. Sprangers,Lydia G. van der Geest,Geert‐Jan Creemers,Susan van Dieren,Jan‐Willem B. de Groot,Bas Groot Koerkamp,Ignace H. J. T. de Hingh,Marjolein Y.V. Homs,Evelien J.M. de Jong,I. Quintus Molenaar,Gijs A. Patijn,Lonneke V. van de Poll‐Franse,Hjalmar C. van Santvoort,Judith de Vos‐Geelen,Johanna W. Wilmink,Casper H.J. van Eijck,Marc G. Besselink,Hanneke W.M. van Laarhoven,(unknown)	2020	11
9	Safety and Feasibility of Additional Tumor Debulking to First-Line Palliative Combination Chemotherapy for Patients with Multiorgan Metastatic Colorectal Cancer The Oncologist ·Elske C. Gootjes,Eric P. van der Stok,Tineke E. Buffart,Lotte Bakkerus,Mariëtte Labots,Barbara M. Zonderhuis,Jurriaan B. Tuynman,Martijn R. Meijerink,Peter M. van de Ven,Cornelis J.A. Haasbeek,Albert J. ten Tije,Jan‐Willem B. de Groot,Mathijs P. Hendriks,Esther van Meerten,Joost J. Nuyttens,Dirk J. Grünhagen,Cornelis Verhoef,Henk M.W. Verheul,(unknown)	2020	11
10	Nationwide Outcomes of Advanced Melanoma According to BRAFV600 Status American Journal of Clinical Oncology ·Jesper van Breeschoten,Michel W.J.M. Wouters,Liesbeth C. de Wreede,Doranne H. Hilarius,John B.A.G. Haanen,Christian U. Blank,Maureen J.B. Aarts,Franchette W.P.J. van den Berkmortel,Jan‐Willem B. de Groot,Geke A.P. Hospers,Ellen Kapiteijn,Djura Piersma,Rozemarijn S. van Rijn,Karijn P.M. Suijkerbuijk,Willeke A.M. Blokx,Albert J. ten Tije,Astrid A.M. van der Veldt,Gerard Vreugdenhil,Marye J. Boers,Alfons J.M. van den Eertwegh	2020	1
11	The Effects of Four Different Tyrosine Kinase Inhibitors on Medullary and Papillary Thyroid Cancer Cells The Journal of Clinical Endocrinology & Metabolism ·Hans H G Verbeek,Maria M. Alves,Jan‐Willem B. de Groot,Jan Osinga,John Th. M. Plukker,Thera P. Links,Robert M.W. Hofstra	2011	68
12	Factors Predicting Outcome of Total Thyroidectomy in Young Patients with Multiple Endocrine Neoplasia Type 2: A Nationwide Long‐Term Follow‐up Study World Journal of Surgery ·Jennifer M. J. Schreinemakers,Menno R. Vriens,Gerlof D. Valk,Jan‐Willem B. de Groot,John Th. M. Plukker,Klaas M. A. Bax,Jaap F. Hamming,Rob B. van der Luijt,Daniël C. Aronson,Inne H.M. Borel Rinkes	2010	27

About Jan‐Willem B. de Groot

Jan‐Willem B. de Groot is a scholar working on Oncology, Geriatrics and Gerontology and Cancer Research, having authored 12 papers that have together received 183 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (4 papers), CAR-T cell therapy research (3 papers), Melanoma and MAPK Pathways (3 papers), Cancer Genomics and Diagnostics (2 papers), Cutaneous Melanoma Detection and Management (2 papers), Colorectal Cancer Surgical Treatments (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (68 citations), Oncology (111 citations) and Cancer Research (19 citations). Jan‐Willem B. de Groot has collaborated with scholars based in Netherlands, Germany and United States. Frequent co-authors include John Th. M. Plukker, Jan Osinga, Maria M. Alves, Thera P. Links, Hans H G Verbeek, Robert M.W. Hofstra, Jennifer M. J. Schreinemakers, Inne H.M. Borel Rinkes, Menno R. Vriens and Rob B. van der Luijt. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, British Journal of Cancer and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact